Solesence Inc (NAS:SLSN)
$ 0.97 -0.030 (-3.03%) Market Cap: 68.51 Mil Enterprise Value: 90.17 Mil PE Ratio: 0 PB Ratio: 5.11 GF Score: 56/100

Q2 2026 Solesence Inc Earnings Call Transcript

Aug 19, 2026 / 09:00 PM GMT
Release Date Price: $0.9405 (+6.15%)

Key Points

Positve
  • Solesence Inc (SLSN) expects to outperform 2025 on a full-year revenue basis, with shipped and on-hand orders for 2026 totaling $64.9 million as of August 17, up from $60 million in the same period last year.
  • The company projects second-half 2026 revenue of approximately $35 million, marking the strongest second-half performance in its history.
  • Gross margin remained stable at 31% in Q2 2026 despite a 25% revenue decline, indicating improved labor efficiency and operational progress under the Transform and Transcend strategy.
  • Solesence Inc (SLSN) is expanding into the high-growth scalp care market with innovative products, including a first-of-its-kind dry shampoo with SPF and a treatment using Whisper technology, targeting a $3 billion addressable segment.
  • The company sees the FDA approval of non-mineral sunscreen (BEMT) as a positive development, planning to launch combination products with its proprietary mineral technologies and boosters, which could expand its market opportunities.
Negative
  • Solesence Inc (SLSN) identified a historical inventory costing methodology issue, leading to a restatement and an NT 10-Q filing, which raises concerns about financial reporting integrity.
  • Q2 2026 revenue declined to $15.3 million from $20.4 million in Q2 2025, primarily due to lower sales from a major product launch that had benefited the prior-year quarter.
  • The company reported a net loss of $158,000 in Q2 2026, compared to net income of $3.2 million in the prior year, and adjusted EBITDA fell to $523,000 from $3.7 million.
  • One-time events, including a $938,000 charge related to Refi and a $1.4 million ERC payment received in Q2 2025, negatively impacted year-over-year profitability comparisons.
  • The accounting restatement and remediation efforts, including enhanced inventory costing processes and controls, may distract management and incur additional costs, potentially affecting near-term operations.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

SLSN.OQ - Solesence Inc
Q2 2026 Solesence Inc Earnings Call
Aug 19, 2026 / 09:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, and thank you for standing by. Welcome to the Solescence second quarter 2026 conference call. Today's call is being recorded. On today's call, we have Kevin Curriton, President and Chief Executive Officer of Solescence, and Laura Ruffin, Chief Financial Officer of Solescence.

During this call, management will make statements that include forward-looking statements.

Within the meaning of the federal securities laws, which are pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1,995.

This conference may contain certain statements that reflect the company's current beliefs and a number of important factors that could cause actual results for further periods to differ
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot